Chenguang Biotech Group Co., Ltd. has been issued a warning letter by the Xinjiang Securities Regulatory Bureau for constituting a non-operating fund occupation of Xinjiang Shengyuan Biotech Co., Ltd. Upon investigation, from March to April 2025, Chenguang Biotech received a total of 136 million yuan in intercompany loans from Tumushuke Shengyuan Biotech Co., Ltd. and Kashgar Shengyuan Biotech Co., Ltd., both wholly-owned subsidiaries of Shengyuan Biotech, as well as from Handan Chenguang Plant Protein Co., Ltd. The funds were repaid with interest in May 2025.
Chenguang Biotech GroupReceived warning letter for non-operating fund occupation, regulatory penalty.
